Trials / Completed
CompletedNCT04006236
Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas
Growth and Tolerance of Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 245 (actual)
- Sponsor
- Abbott Nutrition · Industry
- Sex
- All
- Age
- 0 Days – 14 Days
- Healthy volunteers
- Accepted
Summary
This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental Infant Formula | Feed Ad Libitum |
| OTHER | Control Infant Formula | Feed Ad Libitum |
Timeline
- Start date
- 2019-08-05
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2019-07-05
- Last updated
- 2021-09-24
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04006236. Inclusion in this directory is not an endorsement.